Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| $566.6K |
| -33.9% |
| Open the original filing on SEC.gov |
| Jun 12 | SNDX | Syndax Pharmaceuticals Inc | MEXER◷ | 31,235 | $13.82 | $431.7K | +51.3% | Open the original filing on SEC.gov |
| Jun 11 | SNDX | Syndax Pharmaceuticals Inc | MEXER◷◆ | 22,515 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | SNDX | Syndax Pharmaceuticals Inc | SSELL◷ | 34,280 | $18.00 | $617K | -36.0% | Open the original filing on SEC.gov |
| Jun 11 | SNDX | Syndax Pharmaceuticals Inc | MEXER◷ | 22,515 | $13.82 | $311.2K | +31.0% | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT◆ | 144,700 | $20.43 | $3M | — | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT | 36,000 | — | — | +60.9% | Open the original filing on SEC.gov |
| Feb 4 | SNDX | Syndax Pharmaceuticals Inc | AGRANT | 24,000 | — | — | +68.3% | Open the original filing on SEC.gov |
| May 16, 2025 | SNDX | Syndax Pharmaceuticals Inc | PBUY | 11,765 | $9.00 | $105.8K | +50.3% | Open the original filing on SEC.gov |